Analysis of human Pygopus 2 as an essential androgen-responsive cellular biomarker for prostate cancer progression

分析人类 Pygopu​​s 2 作为前列腺癌进展的重要雄激素反应性细胞生物标志物

• 批准号: 286986
• 负责人: Kao Kenneth R
• 金额: $ 11.15万
• 依托单位: Memorial University of Newfoundland
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-03-01 至 2016-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=286986&lang=en
• 关键词: Androgen Response Factor; Chromatin Modelling; Prostate Cancer; Pygopus

Early detection and diagnosis is thought to be the best way to intervene and cure a potentially deadly cancer. For prostate cancer, which affects 1 in 6 men, a significant proportion of tumors may remain indolent for several years without physically affec

早期发现和诊断被认为是干预和治愈潜在致命癌症的最佳途径。每6名男性中就有1人罹患前列腺癌，其中相当大比例的肿瘤可能会持续数年无痛而不会对身体造成影响